Major corporate developments:
Baiyunshan (00874): a wholly-owned subsidiary plans to participate in investing in the Warburg Capital Healthcare Limited Partnership Fund.
Yuexiu Transport Infrastructure (01052) plans to establish an asset-backed special plan and sell up to 58.43% of the actual equity of the project company.
BeiGene (06160) plans to spend US$19.5 million to participate in Bravera's Series A financing.
Victory Giant Technology (02476) plans to add no more than US$170 million in new investment to its third-tier wholly-owned subsidiary MFSM.
Sinohope Group (01611): a subsidiary plans to subscribe for and purchase listing shares of the Gaoteng Bitcoin ETF with US$10 million.
CDB Financial Leasing (01606) plans to purchase information technology computer equipment for RMB 9.676 billion.
China Oilfield Services (02883) plans to invest in the construction of 59 oilfield work vessels of six types.
China Sanjiang Chemical (02198) plans to spend about US$320 million to acquire two very large ethane carriers.
InnoCare Pharma (09969): zurletrectinib has been included in the 2026 National Medical Insurance Catalog.
Sihuan Pharmaceutical (00460): Xuanzhu Biopharma (02575)'s new indication for piroxibrutinib has been included in the 2026 National Basic Medical Insurance Drug Catalog.
Operating results:
Baidu Group-W (09888) released its third-quarter results, with a net profit of RMB 1.395 billion, turning profitable year-on-year; Apollo Go's fully driverless operation orders in Shenzhen grew about 170% quarter-on-quarter.
Beike-W (02423) released its third-quarter results, with a net profit of RMB 2.195 billion, an increase of 193.9% year-on-year.
H World Group-S (01179) released its third-quarter results, with revenue rising 11.3% year-on-year to RMB 7.8 billion.
XPeng Group-W (09868) reported a third-quarter net loss of RMB 870 million, an increase of 127.89% year-on-year.
Perfect Medical (01830) released its interim results, with profit attributable to shareholders of HK$145 million, an increase of 52.93% year-on-year.
SIS INT'L (00529): New Dragon Thailand's profit attributable to shareholders in the first three quarters was THB 827 million, an increase of 35.13% year-on-year.
Comments